Added to YB: 2024-10-21
Pitch date: 2024-10-20
1SXP.F [neutral]
SCHOTT Pharma AG & Co. KGaA
-50.65%
current return
Author Info
Octopus Value is a private investor focusing on quality companies with margin of safety Sign up for the newsletter.
Company Info
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.
Market Cap
EUR 4.2B
Pitch Price
EUR 31.08
Price Target
N/A
Dividend
0.57%
EV/EBITDA
16.72
P/E
28.61
EV/Sales
4.62
Sector
Life Sciences Tools and Services
Category
growth
#1 Schott Pharma - Qualitative Analysis
1SXP.F (quick dive): Schott Pharma: Glass packaging leader, 2 segments (DCS & DDS). Benefiting from biologics, GLP-1, ready-to-use trends. High switching costs, scale economies, regulatory barriers. Risks: supply chain, customer delays. 52% HVS revenue, targeting 60%. Expanding capacity. Weak incentives. 77% owned by Schott AG.
Read full article (7 min)